EFGARTIGIMOD ALFA

FDA Drug Profile — VYVGART

EFGARTIGIMOD ALFA is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including VYVGART. Available dosage forms: liquid, injection.

Drug Details

Generic Name
EFGARTIGIMOD ALFA
Brand Names
VYVGART
Application Number
BLA761195
Sponsor
Lonza Biologics Tuas Pte.Ltd.
NDC Codes
2
Dosage Forms
LIQUID, INJECTION
Routes
INTRAVENOUS
Active Ingredients
EFGARTIGIMOD ALFA

Indications and Usage

1 INDICATIONS AND USAGE VYVGART is indicated for the treatment of adult patients with generalized myasthenia gravis (gMG). VYVGART is a neonatal Fc receptor blocker indicated for the treatment of adult patients with generalized myasthenia gravis (gMG). ( 1 )